Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Venture Life ( (GB:VLG) ) has provided an update.
Venture Life Group PLC has announced upcoming board changes following the acquisition of Health & Her Limited, which has expanded their presence in the vitamins and minerals market. Due to a potential conflict of interest, Paul McGreevy, the current Non-Exec Chair, will step down, and Mark Adams will assume the role, with plans to find a new non-executive director and Audit Committee Chair. The board expressed gratitude for McGreevy’s contributions, which have significantly enhanced the company’s growth and operational efficiency.
More about Venture Life
Venture Life Group PLC is an international consumer self-care company that develops, manufactures, and commercializes a wide range of products for the global self-care market. With operations in the UK, Italy, The Netherlands, and Sweden, the company’s product portfolio includes items such as Balance Activ for women’s intimate healthcare, Earol for ENT care, and UltraDEX for oral care, among others. The company’s products are primarily available through pharmacies and grocery stores, with direct supply to retailers in the UK and The Netherlands, and through international partners elsewhere.
YTD Price Performance: -12.10%
Average Trading Volume: 184,830
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £44.18M
Learn more about VLG stock on TipRanks’ Stock Analysis page.
